Скачать или смотреть How Minimal Residual Disease and Genetics Guide Myeloma Care – Dr. Martin Kaiser

In this segment, Dr. Martin Kaiser shares how new diagnostic tools like minimal residual disease monitoring (MRD) and genetic risk stratification are transforming the care of patients with high-risk multiple myeloma. He explains how combining MRD monitoring with insights into genomic instability in myeloma can help personalize multiple myeloma treatment and guide decisions about when patients might safely take breaks from therapy.

You’ll also hear about the emerging role of epigenetics in myeloma and how understanding what causes multiple myeloma can help tackle challenges like resistance in multiple myeloma cancer.

What you’ll learn in this video:
▶ How minimal residual disease testing can detect disease activity even when scans look normal
▶ Why genetic risk markers are key for tailoring myeloma treatment plans
▶ The link between genomic instability and rapid disease progression in myeloma cancer
▶ How combining MRD results with genetic risk stratification is improving outcomes for multiple myeloma patients
▶ Why exploring epigenetics in myeloma may open new doors for a potential multiple myeloma cure

This conversation is a must-watch for anyone looking to understand the cutting edge of multiple myeloma diagnosis and how science is moving us closer to lasting remission for myeloma patients.

#highriskmultiplemyeloma #multipmyeloma #myelomacancer #MRD #minimalresidualdisease #geneticrisk #genomicinstability #epigeneticsinmyeloma #myelomadiagnosis #myelomatreatment #myelomacure #drmartinkaiser #mdnewsline